Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
Clinical trial NCT00515892 · UNKNOWN
Trial details
- NCT number
- NCT00515892
- Sponsor
- Cambridge Antibody Technology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.